KEYNOTE SPEAKERS, PANELLISTS & MODERATORS

MAIN STAKEHOLDERS

figure a

Prof. Dr. O. Golubnitschaja, Secretary-General, EPMA

figure b

Dr. V. Costigliola, President of EPMA

HEALTHCARE IN OVERVIEW ACROSS THE GLOBE, ECONOMICS OF PERSONALISED MEDICINE

figure c

Dr. P. Bilinski, Chief of Sanitary Inspector responsible for public health in Poland

figure ea

Mr. G. Nabi Azad, Minister of Health & Family Welfare, India

figure d

Mr. S. S. Gandhiselvan, Minister of State for Health and Family Welfare, India

figure e

Mr. Adoor Prakash, Minister of Health, Kerala State, India

figure f

Dr. A. Benini, Missionary of the Organisation of United Nations; National Representative of EPMA in Denmark

o Dr. R. Maksimovic, Missionary of the World Health Organisation

figure g

Prof. Dr. F. Paul, National Representative of EPMA in Germany

figure h

Dr. K. Grosios, National Representative of EPMA in UK

figure i

Prof. Dr. H. Iso, National Representative of EPMA in Japan

figure j

Dr. M. Kapalla, National Representative of EPMA in Slovak Republic

figure k

Prof. Dr. K. Richter, National Representative of EPMA in Republic of Macedonia (FYROM) and Bavaria (Germany)

figure l

Dr. D. Dimitrov, National Representative of EPMA in Bulgaria

figure m

Prof. Dr. M. Dündar, National Co-Representative of EPMA in Turkey

figure n

Prof. Dr. W. Sai Ho Chan, National Representative of EPMA in Taiwan (ROC)

figure o

Prof. Dr. I. Gozes, National Representative of EPMA in Israel

figure p

Dr. V. Costigliola, President of EPMA

figure q

Dr. K. Krapfenbauer, Vice-President of EPMA

figure r

Dr. W. Spek, EuroBioForum, Managing Director, The Netherlands

GRANTING STRATEGIES IN PPPM

figure s

Prof. Dr. M. Goldman, Director, Innovative Medicines Initiative, EU-Commission, Brussels

figure t

Dr. S. Srivastava, Director, Early Detection Research Network, NIH / NCI, Washington D.C., USA

figure u

Dr. C. Longson, Director, National Institute for Health & Clinical Excellence, UK

figure v

Dr. J.-L. Sanne, Directorate for Personalised Medicine, EU-Commission, Brussels, Belgium

figure w

Dr. L. Kristiansen, Medical Sciences, European Science Foundation, Strasbourg, France

figure x

Prof. Dr. M. Paltsev, Vice-Director of the I. Kurchatov National Centre for Science and Technologies, Russia

figure y

Dr. J. Greuel, Adjunct Professor of Finance & Healthcare Management IE Business School, Madrid, Spain / Managing Director, Bioscience Valuation BSV GmbH, Germany

EDUCATION IN PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE

figure z

Dr. J. Delgado, Head of Unit Vocational Education and Training Policy, Leonardo da Vinci Programme, EU-Commission, Brussels, Belgium

figure aa

Dr. P. Butler, Editorial Director, Biomedicine, Springer

figure ab

Prof. Dr. H.H. Schild, Director of Radiological Hospital, University of Bonn, Germany

figure ac

Dr. M. Roelandse, Associate Editor, Biomedical Unit, Springer

figure ad

Prof. Dr. O Golubnitschaja, Editor-in-Chief, The EPMA J. & Book-Series “Advances in PPPM”, EPMA / Springer

figure ae

Dr. V. Costigliola, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”

figure af

Prof. Dr. M. Mozaffari, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”

figure ag

Dr. S. Mandel, Associate Editor, The EPMA J. & Book-Series “Advances in PPPM”, Vice-President of EPMA

figure ah

Prof. Dr. D. Desiderio, Associate Editor, The EPMA J.

figure ai

Prof. Dr. H. Iso, Associate Editor, The EPMA J.

figure aj

Prof. Dr. M. Scarpa, Associate Editor, The EPMA J.

figure ak

Prof. Dr. O. Topolcan, National Representative of EPMA in Czech Republic

PATIENT NEEDS - CHALLENGES FOR STAKEHOLDERS IN PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE

figure al

Dr. V. Costigliola, President of EPMA

figure am

Dr. J. Mendive, National Representative of EPMA in Spain

figure an

Dr. G. Vittadini, Director of Technology Opportunities, Bracco Imaging

figure dw

Prof. Dr. M. Reiser, ESR Past President, Professor and Chairman, Department of Radiology, Dean of the Medical Faculty, Ludwig Maximilians University Munich, Germany

figure ao

Dr. A. Jansen, Director, DiaDexus

figure ap

Prof. Dr. M. Scarpa, “Brains for Brain”-Foundation

figure aq

Dr. J. Bowis, President of Health First Europe, Vice-President of the European Health Forum Gastein, Chairman of the Health Advisory Board of GlaxoSmithKline

figure ar

Mr. M. Hadder German Federation of Diabetics, Germany

INNOVATIVE PPPM-CENTRES: OVERALL CONCEPT, MEDICAL IMAGING FOR DISEASE PREDICTION AND PREVENTION, INNOVATIVE DIAGNOSTIC TOOLS, NEW PERSPECTIVES IN HEALTHCARE

figure as

Prof. Dr. G. P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The Netherlands

figure at

Prof. Dr. G. Frija, ESR, Paris, France

figure au

Dr. V. Costigliola, General Practitioner, Brussels, Belgium

figure av

Dr. M. Kapalla, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Negentropic Systems, s.r.o, Ruzomberok, Slovakia; National Representative of EPMA in Slovakia

figure aw

Dr. M. Pelsers, “Laboratory Stein GmbH”, Germany

figure ax

Prof. Dr. O. Golubnitschaja, Radiological Hospital, University of Bonn, Germany

figure ay

Dr. K. Krapfenbauer, Medical University of Vienna, Vienna, Austria; Vice-President of EPMA

INFLAMMATION AND AUTOIMMUNITY: RISK ASSESSMENT AND PREDICTIVE APPROACHES THROUGH THE ANALYTICAL ARMAMENTARIUM

figure az

Prof. Dr. S. Suchkov, The I.M. Sechenov First Moscow State Medical University, Russian Academy of Medical Sciences, Russia

figure ba

Prof. Dr. A. Notkins, Scientific Director, NIDCR / NIH, Bethesda, USA

figure bb

Prof. Dr. T. Marshall, Murdoch University of Western Australia

TAILORED PREVENTION: PREDICTIVE, PREVENTIVE AND PERSONALISED CONCEPTS OF TRADITIONAL MEDICINES, PERSONALISED NUTRITION, BODY CULTURE & SPORT MEDICINE

figure bc

Prof. Dr. H. Boecker, University of Bonn, Germany

figure bd

Dr. P. Roberti di Sarsina, Non-Conventional Medicine, High Council of Health, Ministry of Health, Italy

figure be

Prof. Dr. J. G. Ionescu, Specialised Clinic Neukirchen, Germany

figure bf

Prof. Dr. G. Trovato, Catania University, Italy

figure bg

Prof. Dr. K. Richter, University of Nurnberg, Germany; National Representative of EPMA in Republic of Macedonia (FYROM) and Bavaria (Germany)

figure bh

Prof. Dr. A. Kunin, The Voronezh N.N.Burdenko, State Medical Academy, Russia

figure bi

Dr. R. Bubnov, Clinical hospital, State Affairs Department of Administration of the President of Ukraine, Kiev, Ukraine; National Representative of EPMA in Ukraine

PREDICTIVE DIAGNOSTICS AND PERSONALISED MEDICINE IN PAEDIATRICS

figure bj

Prof. Dr. M. Scarpa, University of Padua, Italy, “Brains for Brain”-Foundation

figure bk

Dr. J. Bowis, President of Health First Europe, Vice-President of the European Health Forum Gastein, Chairman of the Health Advisory Board of GlaxoSmithKline

figure bl

Prof. Dr. D. Begley, King’s College London, UK

figure bm

Prof. Dr. T. Cox, University of Cambridge, UK

figure bn

Dr. G. Tsangaris, Proteomics Research Unit, Biomedical Research Foundation, Academy of Athens, Greece; National Representative of EPMA in Greece

figure bo

Prof. Dr. O. Golubnitschaja, University of Bonn, Germany

PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE IN DIABETES CARE

figure bp

Prof. Dr. M. Mozaffari, Georgia Health Sciences University, Augusta, Georgia, USA

figure bq

Prof. Dr. L. Salminen, Ophthalmologic Clinic, University of Tampere, Finland; National Representative of EPMA in Finland

figure br

Prof. Dr. T. Josifova University Hospital Basel, Eye Clinic, Switzerland; National Representative of EPMA in Switzerland

figure bs

Prof. Dr. J. Coelho, Department of Chemical Engineering, University of Coimbra, Portugal; National Representative of EPMA in Portugal

figure bt

Dr. C. Sena, Medical Faculty, University of Coimbra, Portugal

figure bu

Dr. W. Abebe, Georgia Health Sciences University, Augusta, Georgia, USA

figure bv

Dr. R. Krishna, Department of Periodontics, College of Dental Medicine, Augusta, USA

figure bw

M.Sc. M. Cebioglu, Molecular Diagnostics, Department of Radiology, University of Bonn, Germany

figure bx

Prof. Dr. B. Baban, College of Dental Medicine, Georgia Health Sciences University, Augusta, Georgia, USA

PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE IN CANCER

figure by

Prof. Dr. D. Desiderio, University of Tennessee Health Science Center, Memphis, USA

figure bz

Prof. Dr. D. Characiejus, Vilnius University, Lithuania; National Representative of EPMA in Lithuania

figure ca

Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New York, USA

figure cb

Dr. S. Hagan, Glasgow Caledonian University, Scotland

figure cc

Prof. Dr. R. Danesi, University of Pisa, Italy; National Representative of EPMA in Italy

figure cd

Dr. M. Mallmann, University of Bonn, Germany

figure ce

Dr. Ch. Swanton, Translational Cancer Therapeutics Laboratory, London, UK

figure cf

Dr. X. Zhan, University of Tennessee Health Science Center, Memphis, USA

figure cg

Dr. A. González Neira, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; National Co-Representative of EPMA in Spain

figure ch

Prof. Dr. Ch. Gerner, University of Vienna, Austria; National Representative of EPMA in Austria

figure ci

Prof. Dr. O. Topolcan, National Representative of EPMA in Czech Republic

figure cj

Dr. S. Kovalenko, Deputy Director, Institute of Molecular biology and Biophysics, Novosibirsk, Russia

PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE IN NEURODEGENERATIVE DISEASES

figure ck

Dr. S. Mandel, Technion, University of Haifa, Israel; Vice-President of EPMA

figure cl

Prof. Dr. A. Tasker, University of British Columbia, Vancouver, Canada

figure cm

Prof. Dr. Gabriel P. Krestin, Erasmus MC, University Medical Centre Rotterdam, The Netherlands

figure cn

Dr. A. Roses, Duke University and Zinfandel Pharmaceuticals, Inc., USA

figure co

Dr. I. Grossman, Cabernet Pharmaceuticals, USA

figure cp

Dr. O. Weinreb, Eve Topf Centers of Excellence for Neurodegenerative Diseases Research, Rappaport Family Research Institute, Israel

figure cq

Prof. Dr. F. Paul, Charité Berlin, Germany; National Representative of EPMA in Germany

figure cr

Prof. Dr. L. Spiru, President "Ana ASLAN" International Foundation, Bucharest, Romania; National Representative of EPMA in Romania

figure cs

Prof. Dr. D. Muresanu, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), Romania; National Co-Representative of EPMA in Romania

figure ct

Dr. K. Yeghiazaryan, Molecular Diagnostics, Department of Radiology, University of Bonn, Germany

PREDICTIVE, PREVENTIVE AND PERSONALISED MEDICINE IN CARDIOVASCULAR DISEASES

figure cu

Prof. Dr. H. Iso, Osaka University, Japan; National Representative of EPMA in Japan

figure cv

Prof. Dr. P. Evans, British Heart Foundation Cardiovascular Sciences Unit, National Heart and Lung Institute, Imperial College London, UK

figure cw

Prof. Dr. J. Kastrup, The Heart Centre, Rigshospitalet University Hospital Copenhagen, Denmark; National Co-Representative of EPMA in Denmark

figure cx

Prof. Dr. Ch. Gluud, Copenhagen University Hospital, Copenhagen, Denmark; Danish National Coordinator, ECRIN

figure cy

Prof. Dr. H. Rosolova, Charles University in Prague, Medical Faculty in Pilsen, Czech Republic

figure cz

Dr. F. de Meester, DMF-PL, Gliwice, Poland

figure da

Dr. H. Yatsuya, Nagoya University, Japan

figure db

Prof. Dr. J. Polivka, Charles University in Prague, Medical Faculty in Pilsen, Czech Republic

o Dr. Y. Kokubo, Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan

figure dx

Dr. K. Yamagishi, Department of Public health Medicine, University of Tsukuba, Tsukuba, Japan

BIOMARKER DISCOVERY, VALIDATION, STANDARDISATION AND PRACTICAL APPLICATION IN MEDICAL PRACTICE

figure dc

Prof. Dr. M. Ferrari, Centre for Genomics, Bioinformatics, and Biostatistics, San Raffaele Scientific Institute, Milan, Italy

figure dd

Dr. P. Jacon, EDMA Director General, Brussels, Belgium

figure de

Dr. K. Krapfenbauer, Medical University of Vienna, Vienna, Austria; Vice-President of EPMA

figure df

Prof. Dr. J. Kzhyshkowska, Mannheim University of Heidelberg, Germany; National Representative of EPMA in Baden Wuerttemberg (Germany)

figure dg

Prof. W. Lieb, Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Germany

figure dh

Dr. Th. Joos, NMI Natural and Medical Sciences Institute at the University of Tübingen, Germany

figure di

Dr. P. Schulz-Knappe, Protagen AG, Dortmund, Germany

figure dj

Dr. J. Walkenhorst, PROvendis, Germany

figure dk

Dr. E. Moiseeva, Institute of Bioorganic Chemistry, Moscow, Russia

figure dy

Dr. G. Grech, Faculty of Medicine and Surgery, University of Malta Medical School, Department of Pathology, Malta

PATIENT-SPECIFIC MODELLING, BIOINFORMATICS

figure dl

Prof. Dr. H. Lemke, Computer Assisted Radiology and Surgery, CARS

figure dm

Dr. M. Kapalla, Faculty of Medicine, Comenius University, Bratislava, Slovakia; Negentropic Systems, s.r.o, Ruzomberok, Slovakia; National Representative of EPMA in Slovakia

figure dn

Prof. Dr. H. Podbielska, Wroclaw University, Poland; National Representative of EPMA in Poland

figure do

Prof. Dr. L. Berliner, Weill Cornell Medical College of Cornell University, New York, USA

figure dp

Dr. A. Shabo, IBM Research Lab in Haifa, Israel

figure dq

Dr. M. Marcus-Kalish, Interdisciplinary Center for Technology Analysis and Forecasting, Tel Aviv University, Israel

BIOBANKING, ETHICS

figure dr

Prof. Dr. R. Hewitt, European, Middle Eastern and African Society for Biopreservation and Biobanking, France

figure ds

Prof. Dr. H. Everaus, Tartu University Hospital, Tartu, Estonia; National Representative of EPMA in Estonia

figure dt

Prof. Dr. P. Riegman, Erasmus MC Tissue Bank, Erasmus MC Rotterdam, The Netherlands

figure du

Prof. Dr. Ch. Chabannon, Institut Paoli-Calmettes & Université d’Aix-Marseille, France

figure dz

Prof. Dr. P. Hofman, Nice CHU Biobank, Pasteur Hospital, Nice, France

figure dv

Dr. L. Leitsalu, Tartu University, Estonia